Search Results for "Publix Aspirin"
Original Source: Aspirin [Publix Super Markets Inc]
Publix Super Markets, Inc. Aspirin Drug Facts
Matching Channels
Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug
Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...
Cardiovascular diseases (CVD) are the world’s most serious disease, killing 17.1 million people a year. CVDs are a group of disorders affecting the heart and blood vessels. The most...
Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and...
Yellow fever is an acute viral hemorrhagic disease. The virus is a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. The yellow fever virus is transmitted by the bite o...
Matching News
Publix Issues Voluntary Recall on Publix Deli Tri Fruit and Grain Salad
Publix Super Markets is issuing a voluntary recall for Publix Deli Tri Fruit and Grain Salad since it may be adulterated with Listeria monocytogenes. Publix received notification...
Publix Issues Voluntary Recall on Private Label Chicken Tenders Dog Chew Treats
Publix Super Markets is issuing a voluntary recall for Publix Chicken Tenders Dog Chew Treats because it may contain trace amounts of antibiotic residue. The UPC, located on the b...
Aspirin Use and Risk of Macular Degeneration—Reply
In Reply: Dr Nowroozzadeh noted that the examination question used to identify regular aspirin users was inappropriate because persons regularly using aspirin may consume it more than twice per week o...
Aspirin Plus Dipyridamole vs Aspirin Only in Ischemic Stroke
Reports suggest that patients who suffer ischemic stroke while treated with aspirin have less severe strokes than those who aren't on aspirin. How does the addition of dipyridamole effect outcomes?...
An Aspirin a Day Can Take the Eyesight Away
Sturgeon Bay, WI (PRWEB) April 29, 2013 Sturgeon Bay, Wisconsin Chiropractor and Naturopath, Dr. J G Moellendorf, DC, ND, LCP notes that aspirin is one of the most commonly used drugs, with ove...
What Is the Key to Aspirin's Benefit in CRC?
Why does aspirin increase survival only in some colon cancer patients? Dr. David Kerr reports on a study suggesting a PIK3CA mutation may be a predictive marker for use of aspirin as adjuvant therapy....
Aspirin and Cancer Risk and Mortality
Aspirin and cancer risk is in the news again—and the link is still unclear. Two studies published early online in the Journal of Clinical Oncology evaluated the relationship between aspirin and canc...
Aspirin, also known as acetylsalicylic acid, has been used for many years to relieve pain, reduce fevers, and improve inflammation. Aspirin is one of the nonsteroidal anti-inflammatory drugs (NSAIDs)...
Matching PubMed Articles
Can resistance to aspirin be reversed after an additional dose?
Aspirin resistance or aspirin non-responsiveness is a recently described phenomenon which has been consistently associated with an increased risk of cardiovascular events. This study was designed to d...
Aspirin resistance in patients with acute ischemic stroke.
Aspirin is used in ischemic stroke therapy. However, some patients are not responsive to the antithrombotic action of aspirin. The aim of this study was to assess the prevalence of aspirin resistance...
Aspirin for preventing venous thromboembolism.
To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...
Aspirin for preventing venous thromboembolism.
To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...
Aspirin for preventing venous thromboembolism.
To the Editor: In their report on the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) trial, Brighton et al. (Nov. 22 issue)(1) describe a nonsignificant decrease in the rate of recurrent...
